VBI VACCINES
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
VBI VACCINES
Industry:
Biotechnology Clinical Trials Health Care
Founded:
2001-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vbivaccines.com
Total Employee:
101+
Status:
Active
Contact:
16137384178
Email Addresses:
[email protected]
Total Funding:
536.97 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Person Schema Microsoft Amazon S3 AmCharts
Similar Organizations
ACEA BIO
ACEA Biosciences is a biotechnology company that develops and commercializes high-performance microelectronic systems for cell-based assays.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Ascendis Pharma
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Cryosa
CryOSA is a medical device company developing novel treatments for obstructive sleep apnea.
ImaginAb
ImaginAb clinically manages cancer and autoimmune diseases via molecular imaging by re-engineering antibodies into small proteins.
Neurovance
Neurovance is a clinical-stage neuroscience company that discovered and developed centanafadine (CTN) to help adults and children with ADHD.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
Parnell Living Science
Parnell is a fully integrated pharmaceutical company dedicated to finding animal health solutions that matter.
Rational Vaccines
Rational Vaccines is a pre-clinical stage that develops live-attenuated herpes simplex virus vaccines.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2011-09-15 | Epixis | Epixis acquired by VBI Vaccines | N/A |
Investors List
Brii Biosciences
Brii Biosciences investment in Post-IPO Equity - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
Strategic Innovation Fund
Strategic Innovation Fund investment in Grant - VBI Vaccines
K2 HealthVentures
K2 HealthVentures investment in Post-IPO Debt - VBI Vaccines
Pontifax
Pontifax investment in Post-IPO Equity - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Debt - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - VBI Vaccines
OPKO Health
OPKO Health investment in Post-IPO Equity - VBI Vaccines
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - VBI Vaccines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-12 | VBI Vaccines Announces Appointment of John Dillman as Chief Commercial Officer |
Official Site Inspections
http://www.vbivaccines.com Semrush global rank: 3.14 M Semrush visits lastest month: 4.82 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "VBI Vaccines"
VBI Vaccines - Wikipedia
Variation Biotechnologies Inc. (VBI), also known as VBI Vaccines Inc., is a biopharmaceutical company, headquartered in Cambridge, Massachusetts, with research facilities in Ottawa, Ontario, Canada, and a research and manufacturing site in Rehovot, Israel. Its Ottawa facility has approximately thirty … See moreSee details»
VBI Vaccines Inc. - LinkedIn
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.See details»
VBI Vaccines Issues Voluntary Nationwide Recall of All PreHevbrio ...
Nov 15, 2024 · VBI Vaccines Inc. (VBI) is initiating a voluntary nationwide recall of all remaining PreHevbrio ® [Hepatitis B Vaccine (Recombinant); NDC 75052-001-10] (“PreHevbrio”) due to …See details»
CEPI and VBI Vaccines collaborate to advance vaccine …
Mar 10, 2021 · Up to $33m of funding will support development of VBI's enveloped virus-like particle (eVLP) vaccine candidates against COVID-19 variants of concern. Phase 1 clinical study of VBI's eVLP vaccine candidate, …See details»
VBI Vaccines Company Profile 2024: Valuation, Funding
VBI Vaccines Inc is a commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and …See details»
VBI Vaccines Inc. | LinkedIn
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease.See details»
VBI Vaccines Inc - Company Profile and News - Bloomberg Markets
VBI Vaccines Inc. operates as a biopharmaceutical company. The Company develops vaccines to address unmet needs in infectious disease and immuno-oncology. VBI Vaccines offers a …See details»
VBI Vaccines Announces Expanded Strategic Partnership with …
Apr 2, 2024 · VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that it has …See details»
VBI Vaccines Announces Dosing of First Patients in Phase 2b
Sep 7, 2023 · VBI-1901 is a novel cancer vaccine immunotherapeutic candidate developed using VBI’s enveloped virus-like particle (eVLP) technology to target two highly immunogenic …See details»
CEPI boosts 'Coronavirus X' vaccine search with expanded VBI …
December 6, 2022; OSLO, Norway and CAMBRIDGE, MA: The Coalition for Epidemic Preparedness Innovations (CEPI) is expanding its world-leading portfolio of potential variant …See details»
Biotech firm gets US$33M boost for Ottawa-developed COVID-19 …
Mar 10, 2021 · Massachusetts-based VBI Vaccines said Wednesday it’s signed a partnership with the Coalition for Epidemic Preparedness Innovations that will see the European organization …See details»
VBI Vaccines Announces Phase 1b/2a Data and Progress of
Apr 12, 2021 · CAMBRIDGE, Mass. -- (BUSINESS WIRE)-- VBI Vaccines Inc. ( Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful …See details»
Valneva and VBI Vaccines Announce European Partnership for …
Sep 8, 2022 · PreHevbri is the only 3-antigen hepatitis B vaccine, comprised of the three hepatitis B surface antigens of the hepatitis B virus – S, pre-S1, and pre-S2. It is approved for use in the …See details»
VBI Vaccines Announces New Tumor Response Data from …
May 30, 2024 · VBI-1901 is a novel cancer vaccine immunotherapeutic candidate developed using VBI’s enveloped virus-like particle (eVLP) technology to target two highly immunogenic …See details»
VBI Vaccines Announces U.S. FDA Acceptance of BLA Filing for
Feb 2, 2021 · VBI Vaccines Inc. ( Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious …See details»
VBI-1901 Elicits Disease Control in Recurrent Glioblastoma - OncLive
Apr 3, 2024 · VBI-1901 is a novel cancer vaccine immunotherapeutic designed using VBI’s enveloped virus-like particle technology. It is intended to target 2 highly immunogenic …See details»
VBI Vaccines Awarded Up to CAD$56 Million Contribution from
Aug 5, 2020 · VBI Vaccines Inc. ( Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious …See details»
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study …
Sep 8, 2023 · VBI-1901 is a novel cancer vaccine immunotherapeutic candidate developed using VBI’s enveloped virus-like particle (eVLP) technology to target two highly immunogenic …See details»
VBI Vaccines Expands Proprietary Technology Platforms With
Oct 26, 2023 · VBI Vaccines Inc., a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced the development of …See details»
VBI Vaccines Selects Syneos Health as Commercialization ... - Nasdaq
Nov 30, 2020 · VBI Vaccines Inc. ( Nasdaq: VBIV) is a commercial-stage biopharmaceutical company developing a next generation of vaccines to address unmet needs in infectious …See details»